Sonelokimab
M1095-axSpA-202
Phase 2 small_molecule active
Quick answer
Sonelokimab for axial spondyloarthritis is a Phase 2 program (small_molecule) at MoonLake Immunotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- MoonLake Immunotherapeutics
- Indication
- axial spondyloarthritis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active